Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Anti-Aging cocktail shows promise in small pilot study

NCT ID NCT07322224

Disease control Sponsor: BlueBird Age Reversal SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a 17-week program combining lifestyle changes, supplements, and a personalized cell-based treatment in 14 healthy adults aged 45 and older. The goal was to see if the protocol could reduce biological age as measured by DNA methylation clocks. While early results may hint at potential, the small size and lack of a comparison group mean we need much larger studies to know if it really works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
autologous cell-free conditioned media from pro-regenerative cells
What this could lead to
If successful, this could point toward a practical way to slow or reverse biological aging, potentially extending healthspan.
What could go wrong
This is a very small pilot study with only 14 participants and no control group. Results may not be generalizable, and the long-term effects or risks of the cell-based media are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Aug 2024

Finished

Mar 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 45 years or older * Generally good overall health as assessed by the study team * Able and willing to provide written informed consent * Willing to participate in all components of the study protocol, including lifestyle optimisation, nutritional supplementation, blood collection, and scheduled follow-up visits * Able to comply with study procedures for the duration of the intervention and assessments Exclusion Criteria: * Presence of a major medical condition that, in the opinion of the investigators, could affect participation or safety * Any condition requiring hospitalization or emergency medical intervention within the past 12 months * Receipt of anti-aging or longevity treatments within the past six months (e.g., intravenous therapies, regenerative or cellular treatments, structured age-reversal programmes) * Active infectious disease at enrolment * Pregnancy or breastfeeding * Use of systemic immunomodulatory, cytotoxic, or investigational treatments in the prior 3 months * Any condition or circumstance that, in the judgement of the investigators, may interfere with study participation or data integrity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biological aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biological aging Healthy aging Longevity

Contacts and locations

Locations

  • Wellbeing International Foundation

    London, W1G 0PG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.